Executive Summary
The 39 filings in this Officer and Director Change stream (all dated 2026-10-23 window) are dominated by governance housekeeping: routine director resignations, interim CFO and CAO appointments, and succession moves, most explicitly stated as not involving any disagreement with the company.
The material exceptions are Lumen's Q3 2026 preliminary results and CEO appointment (LKQ, materiality 9/10) that withdrew full-year guidance and show a 5.4% parts and services organic decline with Europe down 9.8%, and Ardent Health's recharacterization of former CEO Bonick's separation as a for-Cause termination with about $4.5M of severance discontinued and PRSUs cancelled. Finance-function turnover is elevated, with CFO or principal accounting officer changes at Premier Air Charter, Offerpad, Methode Electronics and AB Commercial Real Estate Debt Fund, and two more executive exits (Acadia's head of R&D and Andersons' CHRO). Capital-related dilution and restructuring appear in Bio Essence, Tessera/BiomX and Reliance Global, while compensation is trending upward at Edesa Biotech (base salaries up roughly 75-84% retroactive to July 2026) and Freshpet. Governance is being refreshed through several independent-director additions (Vivid Seats, Fiserv, Civista, FS Bancorp) and multiple planned retirements in 2026-2027. Overall the market implication is limited for most names, with LKQ and Ardent the main items needing active attention.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Filing types in this digest: 8-K
Tracking the trend? Catch up on the prior US Executive Officer Management Changes SEC digest from October 22, 2026.
Investment Signals (11)
- LKQ Corp ↓ (BEARISH)▲
Q3 2026 revenue $3.32B vs $3.50B (down ~5%), net loss $16-32M including $111M impairments vs $178M net income prior year, adjusted EPS $0.47-0.53 vs $0.84, Europe organic revenue -9.8% with segment margin 4.1-5.1% vs 10.0%, full-year 2026 guidance withdrawn, new CEO Abbate effective Dec 15
- Edesa Biotech ↓ (BEARISH)▲
Executive base salaries raised retroactively to July 1, 2026 (CEO $357,696 to $657,423, +84%; President +76%; CFO +75%), first adjustment since 2023, signalling heavier cash commitment as the company funds its pipeline
- Freshpet ↓ (BULLISH)▲
Nicola Baty's new President role carries $675K base salary, long-term incentive target at least 250% of base and 58,245 RSUs vesting June 30, 2029, a retention-focused package that supports management continuity
- Starz Entertainment ↓ (BULLISH)▲
CFO Scott Macdonald (in role since July 2012) signed a new agreement with $1.06M base and 125% target bonus through September 2028 with a one-year Company extension option, providing finance-leadership continuity
- Children's Place (BULLISH)▲
CFO John Szczepanski received a $550K one-time retention award vesting after six months, which is a signal the board is locking in finance leadership during a period of change
- Tessera Defense (BiomX/HLSQ) (BEARISH)▲
Shares outstanding rose to 25,995,794 from 9,026,478 at the October 5 record date (about 2.9x) after 5,332,617 cashless warrant shares were issued to Mandragola and the equity plan was expanded to 6,000,000 shares, a heavy dilution overhang
- Bio Essence Corp (BIOE) ↓ (BEARISH)▲
Controlling holders with 63.92% of stock expanded the board from three to five directors by written consent and removed the bylaw cap on board size, so governance control is concentrated with minority holders having limited influence
- Reliance Global Group (EZRA) (BEARISH)▲
Non-binding LOI for a GPU cloud asset with $3.375M cash at closing plus $375K at 12 months and $250K in founder fees, while the filing itself states the GPU build-out may require dilutive equity, weakening the 'no dilution' framing
- Ardent Health (ARDT) (BEARISH)▲
Former CEO Bonick's separation recharacterized as for-Cause, cancelling about $4.5M of unpaid cash severance and all unvested PRSUs, with the company reserving other remedies; a signal of strong board action on disclosure failures
- Civista Bancshares (CIVB) (BULLISH)▲
Adds healthcare CEO Jeremy Normington-Slay (Firelands Health, about 2,500 employees) to the bank and holding company boards effective October 21, 2026, a positive governance diversification move with no financial change
- Vivid Seats (SEAT) (BEARISH)▲
Board expanded from eight to nine and Chelsea Grayson added as independent director, bringing independence to six of nine directors while the warrants (SEATW) are delisted from Nasdaq Global Select effective October 26, 2026
Risk Flags (9)
- LKQ Corp / Earnings and Guidance Reset↓ [HIGH RISK]▼
Full-year 2026 guidance withdrawn after Q3 revenue fell to $3.32B from $3.50B and EPS to $0.47-0.53 from $0.84, with Europe segment margin down to 4.1-5.1% from 10.0%; Alvarez & Marsal engaged for European operations
- Ardent Health / Governance and Disclosure↓ [HIGH RISK]▼
Former CEO failed to fully disclose third-party compensation, leading to a for-Cause recharacterization, $4.5M severance discontinued and all unvested PRSUs cancelled; potential for litigation or disclosure review
- Tessera Defense (HLSQ) / Dilution [HIGH RISK]▼
Outstanding shares rose from 9.03M to 26.0M (about 188% increase) between the record date and October 23, 2026, driven by cashless warrant exercises and a 5.3M-share equity plan expansion
- Premier Air Charter (PREM) / Finance Leadership Gap [MEDIUM RISK]▼
CFO Matt Aune resigned effective immediately October 19, 2026, with his 1.5M-share option forfeited; CEO Bonar (principal stockholder via TIPP Investments) is now interim principal financial and accounting officer, creating a concentration of control and no permanent successor
- Offerpad (OPAD) / Repeated Finance Turnover [MEDIUM RISK]▼
CFO Peter Knag departed October 20, 2026, with Andrew Pieper appointed interim CFO and principal accounting officer; combined with the Methode CAO exit and AB fund CFO change, finance-function churn is a sector-wide watch point
- Methode Electronics (MEI) / Accounting Officer Exit [MEDIUM RISK]▼
Chief Accounting Officer Stacie Schulz resigned effective October 30, 2026, with the CFO assuming principal accounting officer duties, adding pressure to a finance team already in a transition window
- Acadia Pharmaceuticals (ACAD) / R&D Leadership [MEDIUM RISK]▼
EVP and Head of R&D Elizabeth Thompson left the employee role October 23, 2026, with consulting only through December 31, 2026, and no successor named, a meaningful pipeline-continuity risk
-
CEO, CFO and three directors resigned in one action, replaced by AllianceBernstein personnel (Coffee CEO, McGrogan CFO), raising questions about investor governance and continuity for a private debt vehicle
- Andersons (ANDE) / Restructuring Impact on Incentives [LOW RISK]▼
CHRO Sarah Zibbel's role eliminated effective October 31, 2026, with her 2025 and 2026 PSUs forfeited, indicating restructuring that may affect retention across the HR function
Opportunities (8)
- LKQ Corp / Turnaround Entry Point↓ (OPPORTUNITY)◆
New CEO Salvatore Abbate starts December 15, 2026, North America performed in line with expectations, and the Europe ERP and volume issues are identified causes, so a stabilisation thesis could emerge if Europe margins recover from 4-5% toward prior 10% levels
- Freshpet (FRPT) / Leadership Build-out (OPPORTUNITY)◆
Nicola Baty's elevation to President with a $675K salary and 250%+ long-term incentive target signals the board is investing in an operator to drive the next growth phase
- Civista Bancshares (CIVB) / Healthcare Board Exposure (OPPORTUNITY)◆
Adding a regional healthcare system CEO to the bank board may support health-sector deposit and lending relationships in Ohio, a potential commercial-banking upside
- Vivid Seats (SEAT) / Independence Upgrade (OPPORTUNITY)◆
Board now six of nine independent with Grayson's appointment, reducing governance discount risk while the warrant delisting clears a capital-structure overhang
- Fiserv (FI) / Payments Expertise (OPPORTUNITY)◆
Raj Seshadri, former Mastercard Chief Commercial Payments Officer and senior advisor to Mastercard's CEO, joins the board effective November 30, 2026, bringing relevant card-network expertise to a company in payments competition
- Lumen Technologies / Compensation Clarity↓ (OPPORTUNITY)◆
Severance plan restructuring with a best-net cutback and no excise gross-up, plus CEO Johnson's enhanced 104-week non-CIC package, reduces future change-of-control cost uncertainty
- Bio Essence (BIOE) / Board Expansion for Growth (OPPORTUNITY)◆
Adding Xiying Zhang and Geoff Fellows effective October 19, 2026 and removing the bylaw board cap gives the company room to recruit additional governance talent, a potential operating catalyst
- Starz Entertainment (STRZ) / Finance Continuity (OPPORTUNITY)◆
Long-tenured CFO Macdonald committed through 2028 with performance-based equity awards linked to Compensation Committee goals, lowering finance-leadership risk for investors
Sector Themes (5)
- Finance Leadership Churn Across Small and Mid Caps◆
At least five filings (Premier Air, Offerpad, Methode, AB Commercial RE Debt Fund, Reliance-related disclosure and Children's Place retention) show CFO or principal accounting officer changes or retention actions in one trading window, with 3 of 5 covered by interim or delegated coverage (CEO, Controller, CFO) and raising a sector-wide governance and internal-control watch item [implication: heightened scrutiny of close processes and SOX controls through the Q3 reporting cycle]
- Board Refresh and Independence Gains◆
Director additions at Vivid Seats (independence to 6 of 9), Fiserv (Seshadri), Civista (Normington-Slay), FS Bancorp (Mullet, an internal exec elevated to board), and Macy's (Connelly as Lead Independent) show a pattern of enlarging or refreshing boards, while multiple planned retirements at Dole, Hormel, Great Elm, Fiserv and Macy's point to 2026-2027 succession activity [implication: governance quality improving, though several retirements create seat vacancies to monitor]
- Executive Compensation Inflation and Retention Tools◆
Edesa Biotech's ~75-84% base salary step-up, Freshpet's 250% LTI target, Children's Place's $550K retention award, Starz's 125% bonus target, and Myers' severance multiplier increase from 2.5x to 3x all point to rising pay levels and retention tools to counter turnover [implication: compensation expense pressure at smaller caps where base pay was historically low]
- Restructuring and Operational Headcount Reduction◆
Andersons eliminated the CHRO role during an HR restructuring, LKQ is using Alvarez & Marsal to advise on Europe, Lumen is simplifying its severance plan, and Ardent is cancelling severance, showing a pattern where cost programs are reaching senior leadership [implication: anticipate further executive-level cost actions in capital-intensive or margin-pressured names]
- Dilution and Capital Structure Clean-up◆
Tessera's 188% share increase from warrant exercises and equity plan expansion, Bio Essence's controlling-holder board action, Limitless X's reduction of Class B preferred designations from 11M to 1.5M, Vivid Seats' warrant delisting and GridAI's board departure show capital-structure simplification alongside dilution risk [implication: investors should track share counts and preferred overhang before assuming per-share value]
Watch List (8)
-
Full-year guidance withdrawn; new CEO Salvatore Abbate starts December 15, 2026; watch for the next guidance reset and Alvarez & Marsal findings on European operations at the Q4 report [date: Q4 2026 results, early 2027]
- Ardent Health (ARDT)👁
For-Cause recharacterization of former CEO Bonick with $4.5M severance discontinued; watch for any litigation, clawback claims or restated compensation disclosures in upcoming filings [date: next 10-Q or 8-K, Nov 2026]
- Tessera Defense / HLSQ👁
Post-dilution share count of 26.0M; watch for further warrant exercises by Mandragola and any additional share issuances under the expanded 6M-share plan [date: ongoing, next 10-Q Nov 2026]
- Premier Air Charter (PREM)👁
CEO Bonar serving as interim principal financial and accounting officer; watch for a permanent CFO appointment and any disclosure about Bonar's dual role as principal stockholder [date: search ongoing, watch for 8-K]
- Offerpad (OPAD)👁
Knag remains Senior Advisor through November 30, 2026; watch for the permanent CFO search outcome and Pieper's interim tenure in the Q3 earnings call [date: Q3 2026 earnings, late Oct/early Nov 2026]
- Acadia Pharmaceuticals (ACAD)👁
No successor to EVP and Head of R&D named; Dr. Thompson's consulting ends December 31, 2026; watch for a new R&D head announcement and pipeline timeline commentary [date: December 31, 2026 consulting end]
- Reliance Global Group (EZRA / XGPU)👁
Non-binding LOI with closing targeted early November 2026; watch for definitive agreement signing, the planned ticker change to XGPU and any dilutive financing tied to GPU build-out [date: early Nov 2026]
- Fiserv (FI)👁
Raj Seshadri joins the board November 30, 2026; Henrique De Castro leaving at the 2027 annual meeting; watch for committee assignments and any further board refresh [date: Nov 30, 2026 and 2027 annual meeting]
Filing Analyses
(39)
23-10-2026
Premier Air Charter Holdings Inc. (PREM) disclosed that CFO Matt Aune resigned effective immediately on October 19, 2026, for personal reasons, with no disagreement with the company and no severance; his unvested option for 1,500,000 shares was forfeited. CEO Sandra J. Bonar was designated interim principal financial officer and principal accounting officer effective October 20, 2026, without additional compensation, while the company searches for a permanent CFO. The filing contains no quantitative financial performance data.
- · Aune's resignation was effective immediately and was not the result of any disagreement with the company on operations, policies, or practices
- · Bonar is the son-in-law relationship link: Ross David Gourdie, President, Secretary and Treasurer, is Bonar's son-in-law, and Bonar is the company's principal stockholder through TIPP Investments LLC
- · Bonar previously served as principal financial officer and principal accounting officer before Aune's June 2026 appointment and was Chairman of the Board from March to May 2025
- · The filing discloses no related-party transactions requiring Item 404(a) reporting beyond those previously disclosed in the FY2025 10-K
23-10-2026
Offerpad Solutions Inc. (OPAD) announced that Chief Financial Officer Peter Knag stepped down effective October 20, 2026, in an amicable departure not tied to any disagreement with the company. Knag will remain as a Senior Advisor through November 30, 2026 to support an orderly transition, and Andrew Pieper, Senior Vice President and Controller, was appointed Interim Chief Financial Officer, also serving as principal financial and principal accounting officer. The filing contains no financial results or quantitative performance data.
- · Knag's separation payments and benefits are governed by his existing employment agreement, though no amounts are disclosed
- · Pieper, age 44, has been with Offerpad since July 2021, previously serving as Director, Financial Reporting and then Vice President, Controller before his August 2025 promotion to SVP, Controller
- · Pieper is a Certified Public Accountant in Arizona and previously worked at KPMG LLP (2004-2009) and Apollo Education Group (2009-2018)
- · Pieper has no arrangements with other persons tied to his appointment, no family relationships with directors or executive officers, and no related-party transaction interest under Item 404(a)
23-10-2026
Tessera Defense and Homeland Security Inc. (NYSE American: HLSQ, formerly BiomX Inc.) issued 5,332,617 restricted shares to Mandragola Ltd. upon cashless warrant exercises tied to its 2026 acquisition of a 60% interest in Dr. Frucht Systems Ltd., and stockholders approved an increase of 5,315,000 shares (to 6,000,000) in the 2026 Equity Incentive Plan at a Special Meeting held October 20, 2026. Shares outstanding stood at 25,995,794 as of October 23, 2026, a substantial increase from the 9,026,478 shares entitled to vote at the October 5 record date, reflecting dilution from warrant exercises. Proposal 1 passed with 3,540,463 votes for, 187,380 against, and 591 abstaining, while the CEO and CFO equity awards are no longer conditioned on stockholder approval.
- · DFSL Warrant issued April 13, 2026 is a five-year cashless warrant with a $0.10 per share floor (as adjusted) and a 9.99% beneficial ownership limit
- · Shares were issued under Section 4(a)(2) and are restricted securities under Rule 144
- · One-for-ten reverse stock split was effected September 9, 2026
- · Proposal 2 (adjournment) was not needed because Proposal 1 passed
- · Votes against and abstentions on Proposal 1 were a small fraction of votes for, but the ~5.3M warrant share issuance materially increased outstanding shares
- · Filing reports CEO and CFO equity awards previously conditioned on stockholder approval are now effective
23-10-2026
Limitless X Holdings Inc. filed a Certificate of Amendment (Exhibit 3.1) reducing the number of shares designated as Class B Convertible Preferred Stock from 11,000,000 to 1,500,000, a decrease of 9,500,000 shares that return to authorized but unissued preferred stock. The Board approved the amendment by unanimous written consent dated October 13, 2026, and the certificate was executed by CEO Jaspreet Mathur on October 19, 2026. The amendment is effective upon filing and, per the Board, does not alter rights of the 1,081,356 outstanding Class B shares, which remain above the new cap.
- · Board approved the amendment by unanimous written consent dated October 13, 2026, under Article IV of the A&R Certificate and Section 151(g) of the DGCL.
- · The Board determined no Class B holder consent was required because the decrease affects only authorized but unissued shares and is not adverse to Class B holders.
- · Outstanding Class B shares (1,081,356) remain below the new 1,500,000 designation, leaving roughly 418,644 undesignated-but-unissued Class B headroom.
- · The Class B Certificate of Designation was originally filed October 23, 2023.
23-10-2026
Powerus Corporation (filing header and signature reference the registrant as Powerus Corporation, trading as PUSA on Nasdaq, while the user referenced Aureus Greenway Holdings Inc (AGH); the filing itself does not mention AGH) entered into an employment agreement on October 17, 2026 with Leah Lunger, a Certified Public Accountant, to serve as Chief Accounting Officer, with a start date of November 16, 2026. Her base salary is $235,000, plus target annual incentive eligibility, a grant of 150,000 non-qualified stock options and 50,000 restricted stock units vesting quarterly over four years, and three months of base salary as severance if terminated without cause. No departure or dissolution of existing officers is disclosed in this filing.
- · Ms. Lunger, age 36, previously served at Red Cat Holdings as CFO (2024-2025), VP of Finance (2023-2024) and Corporate Controller (2020-2023)
- · Prior to Red Cat, Ms. Lunger was Controller of Fat Shark Holdings (2017-2020), later acquired by Red Cat
- · Ms. Lunger has no family relationships with directors or executive officers and no Item 404(a) related-party interests
- · Employment agreement filed as Exhibit 10.1; Cover Page XBRL filed as Exhibit 104
- · Filing references Nasdaq-listed common stock, par value $0.001, under symbol PUSA; company is an emerging growth company
23-10-2026
Retension Pharmaceuticals, Inc. appointed Robert Wong as Vice President, Chief Accounting Officer (Principal Accounting Officer), effective November 2, 2026, under an offer letter dated October 12, 2026. The package includes a $360,000 base salary, a 30% target bonus, a $20,000 sign-on bonus, and an option to purchase 25,000 shares, with no mixed or negative financial performance metrics reported in this filing.
- · Mr. Wong reports to the Chief Financial Officer and will be an Section 16 officer upon Board designation
- · Severance plan participation becomes effective only upon completion of a public or private capital raise of at least $15.0 million
- · Option award is subject to Board approval per the offer letter
- · Role is remote and Mr. Wong is a certified public accountant with prior roles at Cytokinetics (2019-2024) and Genentech (1996-2019)
23-10-2026
Empire District Bondco, LLC, a Delaware financing subsidiary of The Empire District Electric Company, disclosed that Tim Wilson stepped down as Manager and President effective October 22, 2026, with no disagreement with the Company cited. Michael Considine, currently SVP, Utility Ops President Missouri at Algonquin Power & Utilities Corp. (the indirect parent), was appointed Manager and President effective the same date. The filing reports no material financial results, amounts, or performance metrics.
- · Mr. Wilson's departure was not due to any disagreement with the Company on operations, policies, or practices
- · Mr. Considine has held his Algonquin role since October 19, 2026, three days before his appointment
- · Mr. Considine previously served as Vice President of Power Delivery Operations Services at Entergy Services
- · No related-party transactions under Item 404(a) of Regulation S-K and no family relationships disclosed for Mr. Considine
- · Filing is administrative in nature; the registrant is a debt-issuing vehicle with no securities listed on an exchange (Section 12(b) securities N/A)
23-10-2026
AB Commercial Real Estate Private Debt Fund, LLC disclosed that directors Peter Gordon, Marguerite Brogan and Edward Gellert resigned from the Board effective October 23, 2026, with Clark Coffee, Mark Manley and Alexander Chaloff appointed as new Directors effective the same date. CEO Peter Gordon and CFO Marguerite Brogan also resigned, with Clark Coffee named CEO and Shane McGrogan named CFO, all effective October 23, 2026. The filing states the resignations were not due to any disagreement with the Fund on operations, policies, practices, financial disclosures, accounting or legal matters.
- · The Fund's Board and executive leadership are being largely replaced by AllianceBernstein personnel, with the incoming CEO, General Counsel and a CIO all drawn from AB's real estate debt and legal functions.
- · Shane McGrogan, the incoming CFO, joined AB in 2017 and is a CFA charterholder responsible for cash-management, accounting, operations and portfolio analytics.
- · Mark Manley previously served as AB's Chief Compliance Officer from 1988 until 2021 and has been with AB since 1984.
- · Fund is an emerging growth company per cover page checkbox.
- · No family relationships or Item 404(a) related-party transactions were disclosed for the incoming directors and officers.
23-10-2026
Nixxy, Inc. (NASDAQ: NIXX) appointed Robert Reda to its Board of Directors effective October 19, 2026, where he will chair the Nominations Committee and serve on the Audit and Compensation Committees. Lillian Mbeki resigned from the Board the same day, effective immediately prior to Mr. Reda's appointment, and the filing states her resignation was not due to any disagreement with the Company. Mr. Reda receives 50,000 shares under the 2025 Equity Incentive Plan, additional annual share grants vesting quarterly, and a $2,500 monthly payment.
- · Board has standing Audit, Compensation, and Nominations Committees; Mr. Reda chairs the Nominations Committee
- · Mr. Reda has no family relationship with any officer or director and no related-party transactions reportable under Item 404(a)
- · Ms. Mbeki's resignation was not the result of any disagreement with the Company on operations, policies, or practices
- · Company is an emerging growth company listed on NASDAQ Capital Market under symbol NIXX; the filing covers the Item 5.02 disclosure only and includes no financial results
23-10-2026
Dole plc (DOLE) filed an 8-K under Item 5.02 disclosing that Non-Executive Director Helen Nolan, who has served on the Board since 2021, intends to retire effective December 31, 2026. The Company thanked Ms. Nolan for her service. No replacement director or other compensatory arrangement was disclosed in this filing.
- · Ms. Nolan's retirement from the Board takes effect December 31, 2026
- · Ms. Nolan has served on the Board since 2021
- · The filing does not name a successor or announce a new director appointment
- · The filing was signed by CFO Jacinta Devine
23-10-2026
Reliance Global Group (Nasdaq: EZRA) announced a non-binding letter of intent, executed September 23, 2026, to acquire the assets of a GPU cloud provider and marketplace operator, marking its entry into the AI cloud market. Consideration is all-cash with no share issuance, totaling $3.375M at closing (including $375K in escrow), a further $375K at 12 months, and $250K in founder consulting fees, all subject to milestones where noted; the company states it is debt-free and that closing is anticipated in early November 2026. The company also plans to rebrand as GPU Exchange and change its Nasdaq ticker from EZRA to XGPU, though the transaction remains unclosed and definitive agreements are not yet signed.
- · LOI is non-binding and executed September 23, 2026; the filing discloses that closing is not yet complete and definitive agreements remain unsigned
- · Milestone conditions apply to both $375K payments; the $500K investment in the seller's related company is optional
- · Forward-looking statements flag that the Company's GPU fleet build-out will require capital beyond the acquisition cost and may be funded through dilutive equity financings, qualifying the 'no dilution' framing
- · Risks flagged include possible loss of customers, GPU providers or key personnel, and Nasdaq continued-listing compliance
- · Ticker change to XGPU is planned but the effective date will be announced separately; shares currently trade under EZRA
23-10-2026
Hormel Foods Corporation (HRL) disclosed on October 21, 2026 that director Sally J. Smith will retire from the Board of Directors effective upon expiration of her current term at the 2027 Annual Meeting of Stockholders, and will not stand for re-election. The company states the decision was not due to any disagreement with the Company. The filing reports a board departure only and contains no financial results or quantitative performance data.
- · Director's departure is not related to any disagreement with the Company
- · Board seat will become vacant following the 2027 Annual Meeting of Stockholders
23-10-2026
LQR House Inc. (Nasdaq: YHC) disclosed in an 8-K filed October 23, 2026 that Chief Marketing Officer Jaclyn Hoffman resigned effective immediately on October 20, 2026, including from all other positions with the company and its subsidiaries and affiliates. The filing states the resignation was not the result of any disagreement with the company on its operations, policies, or practices. No successor, financial terms, or compensatory arrangements were disclosed in this filing.
- · Resignation covers all other roles held by Ms. Hoffman at the company, subsidiaries, and affiliates (officer, director, employee, manager, authorized signatory, representative)
- · No disagreement with the company was cited as the reason for the departure
- · Filing discloses no successor CMO and no separation or compensatory terms
23-10-2026
Myers Industries, Inc. (NYSE: MYE) adopted an amended and restated Senior Officer Severance Plan on October 22, 2026, covering its senior officers including CEO Aaron Schapper, CFO Samantha Rutty, Chief Legal Officer Kari Brashear, and SVP/Chief HR Officer Lorelei Evans. The amendments increase the change-in-control severance multiplier for the CEO from 2.5x to 3x, add a 2x tier for the Executive Leadership Team, and include Target Bonus alongside Base Salary in severance calculations outside the change-in-control period. The filing reports no departure or appointment of an officer; the Item 5.02 designation relates to compensatory arrangements.
- · Prior Plan first adopted effective February 21, 2020 (reported in 8-K filed February 27, 2020) and amended and restated effective April 26, 2023 (reported in 8-K filed April 28, 2023)
- · Full terms are in Exhibit 10.1, the Senior Officer Severance Plan
23-10-2026
Howard Hughes Holdings Inc. disclosed in an 8-K dated October 23, 2026 that Ms. Verbinskaya has departed from her role at the company, effective around October 20, 2026. The company states the departure was not the result of any disagreement relating to its operations, policies or practices, including accounting principles, financial statement disclosure, or internal control over financial reporting. The filing was signed by Chief Legal Officer & Secretary Joseph Valane.
- · The departure is stated to be unrelated to any disagreement with the Company on operations, policies, accounting, financial statement disclosure, or internal control over financial reporting.
- · The excerpt references a fiscal year ending December 31, 2026, suggesting a timing or transition reference tied to that period, though the full context is truncated.
23-10-2026
Brightline Interactive, Inc. (the filing names Brightline Interactive, Inc., trading as BTLN on Nasdaq, not Glimpse Group/VRAR as stated in the request) disclosed that director Tamar Elkeles resigned effective October 19, 2026, from the Board and as Chair of the Compensation and Nominating and Corporate Governance Committees, with no disagreement with the company cited. The Board appointed Admiral Scott Swift, USN (Ret.) as Chair of the Nominating and Corporate Governance Committee and Major General Pete Fesler, USA (Ret.) as Chair of the Compensation Committee.
- · Filing date is October 23, 2026; the resignation event date is October 19, 2026.
- · Resignation was stated to be unrelated to any disagreement with the company on operations, policies, or practices.
- · Common stock trades under symbol BTLN on The Nasdaq Stock Market LLC; registrant is incorporated in Nevada (Commission File No. 001-40556).
23-10-2026
Vivid Seats Inc. (SEATW/SEAT) disclosed that on October 20, 2026 its Board increased its size from eight to nine directors and elected Chelsea Grayson as a Class II director to fill the resulting vacancy, effective immediately, with a term running to the 2029 annual meeting. The Board determined Ms. Grayson is Nasdaq-independent, bringing independent directors to six of nine, and she will receive a $40,000 monthly cash fee in lieu of standard non-employee director compensation. The filing also notes the pending delisting of the company's warrants (SEATW) from the Nasdaq Global Select Market effective October 26, 2026.
- · Ms. Grayson's term runs until the 2029 annual meeting of stockholders; she is not expected to serve on any standing committees
- · Martin Taylor's resignation (December 19, 2025) had reduced the board from nine to eight directors; this appointment refills that seat
- · Ms. Grayson is entitled to indemnification on the same terms as executive officers and other directors
- · No related-party transactions under Item 404(a) and no arrangement or understanding with others for her selection
- · Nasdaq filed a Form 25 on October 16, 2026 to delist the SEATW warrants effective October 26, 2026 and deregister them under Section 12(b) after 90 days
23-10-2026
Freshpet's Board Compensation and Human Capital Management Committee approved an enhanced compensation package for Nicola Baty, effective October 21, 2026, in connection with her appointment as President, while she continues as Chief Operating Officer. The package includes a $675,000 annual base salary, a long-term equity incentive target of at least 250% of base salary, a grant of restricted stock units covering 58,245 shares vesting fully on June 30, 2029 subject to continued employment, and an annual cash bonus target of at least 80% of base salary. The filing discloses no material interest or family relationships requiring disclosure.
- · RSUs vest in full on June 30, 2029, subject to Ms. Baty's continued employment through that date
- · Business experience is incorporated by reference from the April 27, 2026 definitive proxy statement (Schedule 14A)
23-10-2026
Macy's, Inc. disclosed that director Paul C. Varga will resign from the Board effective December 11, 2026, after serving as a director since 2012 and as Lead Independent Director since 2021. The Board has elected Deirdre P. Connelly to succeed him as Lead Independent Director effective December 12, 2026, and will reduce the Board to nine directors. The company states the resignation is part of routine governance and succession planning and was not due to any disagreement with the company, its Board, or management.
- · Varga's resignation takes effect December 11, 2026; Connelly's Lead Independent Director appointment takes effect December 12, 2026
- · The company explicitly states there was no disagreement with the company, Board, or management regarding operations, policies, or practices
23-10-2026
Mobility Global Inc. (MBGL) disclosed that on October 21, 2026, its Nominating and Compensation Committee approved one-time restricted stock unit (RSU) awards to Scott Fredericks (President, CARFAX) and Joseph S. LaFeir (President, Mobility Business Solutions), to be granted December 1, 2026 under the 2026 Long Term Incentive Plan. Award values are $1,250,000 for Mr. Fredericks and $1,000,000 for Mr. LaFeir, vesting in three equal annual installments. The filing reports no departures, and it does not contain financial results or performance comparisons.
- · Grant date for the RSU awards is December 1, 2026, with approval by the Nominating and Compensation Committee on October 21, 2026
- · The awards are described as one-time grants, and the specific award agreement terms have not been disclosed in this filing
23-10-2026
SiTime Corporation (SITM) disclosed that Class III director Katherine E. Schuelke notified the Board on October 19, 2026 of her resignation from the Board, the Nominating and Corporate Governance Committee, and the Compensation and Talent Committee, effective October 20, 2026. The company states the resignation was not due to any disagreement with the Company or the Board on operations, policies, or practices, and the Board reduced its size from nine to eight directors effective the same date.
- · Resignation is effective October 20, 2026, one day after notice was given on October 19, 2026
- · Ms. Schuelke also exits two Board committees: Nominating and Corporate Governance and Compensation and Talent
- · Filing explicitly states the resignation was not the result of a disagreement with the Company or Board
23-10-2026
Barnes & Noble Education (BNED) director and Audit Committee member Kate Eberle Walker notified the company on October 22, 2026 of her resignation, effective December 1, 2026, to accept a role leading the US Higher Education business unit of Pearson, plc. The Corporate Governance and Nominating Committee is currently identifying a replacement for both the board seat and the Audit Committee position.
- · Resignation effective date is December 1, 2026
- · Walker is leaving to lead Pearson's US Higher Education business unit, a direct competitor-adjacent move in the education sector
- · Departure also vacates a seat on the Audit Committee, requiring a replacement for committee coverage
23-10-2026
Starz Entertainment Corp. disclosed that its wholly owned subsidiary Starz Entertainment, LLC entered into a new employment agreement dated October 20, 2026 (effective October 1, 2026) with CFO Scott Macdonald, who has served as CFO since July 2012. The agreement runs through September 30, 2028, with a Company option to extend one year to September 30, 2029, and sets a base salary of $1,060,000 with a 125% target bonus. The filing is a contract continuation of an existing executive rather than a leadership change, and it does not report any negative or flat financial performance metrics.
- · Agreement term runs October 1, 2026 to September 30, 2028, with a one-year Company-elected extension to September 30, 2029
- · Performance-based equity awards vest based on goals set by the Compensation Committee and the CEO
- · Equity awards remain subject to Compensation Committee approval and funding each cycle
- · Change-in-control protection provides single-trigger-free double-trigger acceleration only if a qualifying termination occurs within six months after the change in control
23-10-2026
The Children's Place, Inc. granted its Chief Financial Officer, John Szczepanski, a one-time cash retention award of $550,000 on October 19, 2026, under a letter agreement. The award vests on the six-month anniversary of the effective date if he remains employed in good standing, with repayment required on a for-cause termination, retirement, or resignation, but not on a termination without cause (subject to a release of claims).
- · The Retention Award is payable on the next administratively practicable payroll date after the Effective Date
- · The Retention Letter will be filed as an exhibit to the Form 10-Q for the quarter ending October 31, 2026
- · Repayment obligation lapses if the CFO is terminated without cause, subject to a release of claims
23-10-2026
Methode Electronics disclosed that Chief Accounting Officer and principal accounting officer Stacie Schulz has resigned to pursue other opportunities, effective October 30, 2026. The company states the departure is not due to any disagreement with its auditors, management, or on accounting, disclosure, or internal control matters. CFO Laura Kowalchik will assume the principal accounting officer responsibilities as of the effective date.
- · Resignation notice was given on October 19, 2026, with an effective date of October 30, 2026
- · Company explicitly states no disagreement with independent auditors or management on accounting principles, financial statement disclosure, or internal controls
- · Biographical details for Kowalchik are incorporated by reference from the Form 10-K for the fiscal year ended May 2, 2026, filed June 24, 2026
- · No new compensatory arrangements or successor appointment for the Chief Accounting Officer role were disclosed
23-10-2026
Acadia Pharmaceuticals disclosed that Elizabeth H.Z. Thompson, Ph.D., Executive Vice President and Head of Research and Development, will no longer serve as an employee or in her former role as of October 23, 2026, following a previously disclosed planned retirement for personal reasons. Dr. Thompson will be retained as a consultant through December 31, 2026, and the company is searching for a replacement.
- · Dr. Thompson first informed the company of her planned retirement on April 27, 2026, which was previously disclosed in an 8-K filed May 1, 2026
- · Dr. Thompson's consulting services are limited in scope and expected to run through December 31, 2026
- · Filing notes the possibility that Dr. Thompson may decide not to serve as a consultant
23-10-2026
Ardent Health, Inc. (ARDT) disclosed that its Board determined on October 19, 2026 that former President and CEO Martin J. Bonick's separation, originally effective June 2, 2026 under a June 26, 2026 Separation Agreement, should be recharacterized as a termination for "Cause" because he failed to fully disclose compensation received from third parties required to be reported under Company policies. As a result, the Company will discontinue approximately $4.5 million of unpaid cash severance and cancel all outstanding unvested performance-based restricted stock units (PRSUs), while reserving its rights to pursue other remedies. The Company stated that none of its financial statements or previously disclosed financial results require revision.
- · Board determined Bonick failed to fully disclose third-party compensation required to be reported under Company policies
- · Separation recharacterized from termination without Cause to termination for Cause, effective as of June 2, 2026
- · Company reserved rights to pursue any and all other remedies against Bonick
- · Company determined no financial statements or previously disclosed financial results require revision or correction
23-10-2026
GridAI Technologies Corp. (Nasdaq: GRDX) disclosed that director Manpreet Uppal resigned from the Company's Board of Directors and from all Board committees on which he served, effective October 19, 2026. The filing states the resignation was not the result of any disagreement with the Company on its operations, policies, or practices. No replacement director or committee reassignment was disclosed in this filing.
- · Filing is an Item 5.02 8-K dated October 23, 2026, with the triggering event on October 19, 2026
- · Company's common stock, par value $0.0001, trades under symbol GRDX on the Nasdaq Capital Market
- · Company is headquartered in Boca Raton, Florida and is incorporated in Delaware
- · Jason D. Sawyer, identified as Interim Chief Executive Officer, signed the filing
- · Company states it thanks Mr. Uppal for his service
23-10-2026
The Andersons, Inc. (ANDE) notified Executive Vice President and Chief Human Resources Officer Sarah J. Zibbel on October 21, 2026 that her position is being eliminated as part of a restructuring of the human resources department, with employment terminating October 31, 2026. She will receive severance benefits under the Company's Change in Control & Severance policy, retain her outstanding restricted stock units, and receive a pro-rated portion of 2024 performance share units earned through the three-year period ending in 2026, while her 2025 and 2026 PSUs will be forfeited.
- · Termination effective October 31, 2026, roughly ten days after the notice date
- · Ms. Zibbel's 2025 and 2026 PSU grants will be forfeited
- · Retention of outstanding RSUs and pro-rated eligibility for 2024 PSUs tied to actual performance through 2026
23-10-2026
Edesa Biotech's Board approved base salary increases, retroactive to July 1, 2026, for CEO Dr. Pardeep Nijhawan (from $357,696 to $657,423), President Dr. Michael Brooks (from $335,340 to $591,681), and CFO Peter Weiler (from $300,000 to $525,938). These are the first executive base salary adjustments since 2023, representing increases of roughly 84%, 76%, and 75% respectively. Nijhawan's salary will continue to be paid 90% in fully vested restricted share units under the 2019 Equity Incentive Compensation Plan, as previously disclosed.
- · Salary increases are retroactive to July 1, 2026, implying a catch-up payment for the intervening months
- · Prior executive base salary adjustments occurred in 2023, so these are the first changes in roughly three years
- · Compensation Committee recommended the increases to the Board; employment agreements are referenced as filed with the FY2025 Form 10-K (filed December 12, 2025)
23-10-2026
Great Elm Group, Inc. (Nasdaq: GEG, GEGGL) disclosed that director Eric Scheyer has notified the Board on October 21, 2026 of his decision not to stand for re-election at the 2026 Annual Meeting of stockholders. He will continue to serve as a director until that meeting. The company states the decision was not the result of any disagreement with management or the Board on operations, policies, or practices.
- · Scheyer's departure from the Board takes effect at the 2026 Annual Meeting; he remains a director until then
- · Disclosure explicitly states no disagreement with the Company on operations, policies, or practices
- · Filing signed by CFO Keri A. Davis and dated October 23, 2026
23-10-2026
LKQ Corporation preliminarily reported third quarter 2026 revenue of $3.32 billion, down from $3.50 billion a year earlier, with a parts and services organic revenue decline of 5.4%. The company posted a net loss of $16 million to $32 million, including $111 million of non-cash impairment charges, versus net income of $178 million in Q3 2025; adjusted diluted EPS fell to $0.47–$0.53 from $0.84. The results were driven primarily by Europe, where organic revenue fell 9.8% and segment EBITDA margin compressed to 4.1%–5.1% from 10.0%, while North America performed in line with expectations and Specialty was only modestly below. The Board also appointed Salvatore A. Abbate as President and CEO effective December 15, 2026, withdrew full-year 2026 guidance, and engaged Alvarez & Marsal to advise on European operations.
- · North America performed in line with company expectations despite softer market conditions, and Specialty was only modestly below expectations.
- · Europe weakness was attributed to operational disruptions from the Germany ERP implementation and volume declines in the UK and Benelux.
- · Q3 2026 includes $0.42 per share of non-cash impairment charges, and $23 million of impairment on net assets held for sale.
- · Full-year 2026 guidance, last updated July 30, 2026, has been withdrawn.
- · Interim leadership is provided by an Office of the Chief Executive Officer comprising Chairman John Mendel and Audit Committee Chair Sue Gove until Abbate's December 15, 2026 start.
- · Full third quarter results and a conference call are scheduled for October 29, 2026; preliminary figures are unaudited and may differ materially from final results.
23-10-2026
Fiserv appointed Raj Seshadri, a former Mastercard executive, as an independent director effective November 30, 2026. Director Henrique De Castro informed the company he will not stand for re-election at the 2027 annual shareholder meeting, though he will serve until that meeting and the company states his decision was not due to any disagreement with management.
- · Seshadri has been Senior Strategic Advisor to Mastercard's CEO since August 2026, after serving as Mastercard's Chief Commercial Payments Officer (2024-2026) and President, Data and Services (2020-2024)
- · Seshadri has served on the board of Raymond James Financial, Inc. since 2019
- · Seshadri will receive standard non-employee director compensation and enter the company's indemnity agreement; no related-party transactions under Item 404(a) were disclosed
23-10-2026
The Federal Home Loan Bank of Boston's board declared four directors-elect from its 2026 Annual Director Election, with terms running January 1, 2027 through December 31, 2030: member directors Christopher J. Logan (Bank of New Hampshire) and Caroline R. Carpenter (National Bank of Middlebury), and independent directors Duncan Barnard (CLS Bank) and Robert Tourigny (NeighborWorks Southern New Hampshire, public interest independent). The board also approved the 2027 Director Compensation Policy, which is unchanged from 2026, with per-meeting fees, quarterly retainers, and maximum annual compensation caps (e.g., $165,000 total maximum for the Chair). The filing is an administrative governance disclosure with no financial performance metrics, so there are no negative or declining results to report.
- · Board has not yet determined committee assignments for the Directors-elect for 2027
- · Compensation policy is unchanged from the 2026 Director Compensation Policy
- · Board may reduce or eliminate a director's final quarterly retainer for attendance below 75% or consistent lack of engagement
- · Directors may defer compensation under the Bank's nonqualified, unfunded deferred compensation plan
- · Election was conducted online with no in-person member meeting
23-10-2026
FS Bancorp, Inc. (NASDAQ: FSBW) announced that President and CEO Matthew D. Mullet has been appointed to its Board of Directors and the Board of 1st Security Bank of Washington, effective October 22, 2026. Mullet has served as President since July 2024, became CEO of the Bank in September 2025 and of the Company in June 2026, and joined the Company in July 2011 as CFO. The filing discloses a board appointment of an existing executive rather than a change in executive leadership, and contains no quantitative financial results.
- · Mullet's appointment was proposed by the Governance Nominating and Culture Committee and ratified by the full Board.
- · Mullet began his banking career in June 2000 as a financial examiner with the Washington State Department of Financial Institutions, Division of Banks.
- · Mullet serves on the Board of the Washington Bankers Association and its Government Relations Committee, and on the Seattle Branch board of the Federal Reserve Bank of San Francisco.
23-10-2026
Bio Essence Corp (BIOE) shareholders holding 63.92% of outstanding common stock approved by written consent, in lieu of a meeting, the appointment of Xiying (Thea) Zhang and Geoff Fellows as directors, effective October 19, 2026, expanding the board from three to five members. The consent also amended the bylaws to remove the prior cap on the number of directors, now allowing between one and ten directors.
- · Consenting shareholders Yin You (13,390,000 shares) and Jian Yang (21,000,000 shares) executed the consent, dated October 19, 2026, under California Corporations Code section 603(a) and the company's bylaws
- · The consent was filed under Items 5.02 (Departure/Election of Directors) and 5.03 (Amendments to Articles/Bylaws)
23-10-2026
BuzzFeed, Inc. disclosed that Chief Legal Officer and Corporate Secretary David Arroyo resigned, announced October 19, 2026 and effective November 6, 2026, to pursue other opportunities. He is not entitled to severance, and the company states the resignation was not due to any disagreement or operational, policy, or practice matter. Legal responsibilities will be absorbed by the existing legal team while a replacement is sought.
- · Resignation effective November 6, 2026
- · No severance benefits payable to Mr. Arroyo
- · Company explicitly states no disagreement with management or matters relating to operations, policies, or practices
- · Interim coverage provided by existing legal team pending a search for a replacement
23-10-2026
Lumen Technologies amended and renamed its Executive Severance Plan to the Lumen Severance Plan, removing the CEO Kate Johnson and other named executive officers as participants and terminating their individual change-of-control agreements with their consent. Participating officers now receive substantially the same severance benefits under a new participation agreement, and CEO Johnson's restated agreement retains enhanced terms (104 weeks of base salary plus target bonus on a non-CIC termination; 2.5x salary plus target bonus on a CIC termination) while removing her non-compete to comply with Washington HB 1155, effective June 30, 2027.
- · CEO Kate Johnson's restated agreement supersedes her Change of Control Agreement effective November 7, 2022
- · Excise tax under IRC Section 4999 applies with a best-net cutback and no gross-up for all Participating Officers
- · Johnson's non-compete is removed to comply with Washington Engrossed Substitute House Bill 1155, effective June 30, 2027
- · Restated agreement conforms the definition of 'good reason' to the New Executive Severance Plan
Get daily alerts with 11 investment signals, 9 risk alerts, 8 opportunities and full AI analysis of all 39 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: US Executive Officer Management Changes SEC
October 21, 2026
US Executive Officer Management Changes SEC — October 21, 2026
October 20, 2026
US Executive Officer Management Changes SEC — October 20, 2026
October 19, 2026
US Executive Officer Management Changes SEC — October 19, 2026
October 16, 2026
US Executive Officer Management Changes SEC — October 16, 2026
🇺🇸 More from United States
View all →October 23, 2026
US Pre-Market SEC Filings Roundup — October 23, 2026
US Pre-Market SEC Filings Roundup
October 23, 2026
US Merger & Acquisition SEC Filings — October 23, 2026
US Merger & Acquisition SEC Filings
October 23, 2026
USA Insider Trading Pulse — October 23, 2026
USA Insider Trading Pulse
October 23, 2026
US Corporate Board Director Changes SEC Filings — October 23, 2026
US Corporate Board Director Changes SEC Filings